secwatch.observer — SEC 8-K summary
======================================

Issuer:     Summit Therapeutics Inc. (SMMT)
CIK:        0001599298
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001599298-25-000116
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Summit Therapeutics stockholders approve all proposals at 2025 annual meeting
-----------------------------------------------------------------------------

- All nine director nominees elected (Duggan, Zanganeh, Soni, Clark, Booth, Cesano, Xia, Ronaghi, Huber) with >98% support.
- Ratification of PwC as independent auditor for FY2025 approved: 653,328,708 for, 195,007 against, 233,629 abstain.
- Non-binding say-on-pay resolution approved: 607,320,353 for, 16,607,648 against, 177,556 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599298/000159929825000116/0001599298-25-000116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599298/000159929825000116/smmt-20250612.htm
  HTML page:      https://secwatch.observer/filing/0001599298-25-000116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer